AI-generated summary
This review considers photobiomodulation, the use of red to near-infrared light on body tissues, as a possible non-invasive treatment for epilepsy. The authors report that recent animal model studies showed reduced seizure-like activity and improved neuronal survival, and that the treatment has little or no evidence of side effects. The abstract does not describe the number of studies included, and the evidence cited comes from animal models.
- Who or what was studied
- Animal models of epilepsy (as described in recent studies cited by the review)
- Limits stated in the abstract
- The evidence discussed comes from animal models, and the abstract does not report human trials or the number of studies reviewed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.